NF2 and meningioma: ,2 The latest update from consortium to inform molecular and practical approaches to CNS tumor taxonomy-not official WHO (cIMPACT-NOW) suggest that meningiomas with 1p deletion and concurrent NF2 mutations and/or 22q monosomy should be graded at minimum as CNS WHO grade 2 tumors.3